About the Study

Chronic Kidney Disease (CKD): A study on ferric citrate to maintain or improve iron and phosphate levels

The purpose of this placebo-controlled study is to determine how well ferric citrate will lower the level of FGF23, maintain or correct anemia and iron levels in the blood and maintain normal levels of serum phosphate in children with CKD stages 3 and 4 that is, between 15% and 60% of normal function. Ferric citrate is an oral medication that is approved by the U.S. Food and Drug Administration (FDA) for use in adults with kidney disease to control serum phosphate levels, but it has not been approved for use in children. The use of ferric citrate is considered investigational, which means it has not been approved for the way it is being used in this study.

Interested in learning more?

Full Study Name: FIT4KID - Ferric citrate drug study for children with CKD